Bile Duct Cancer Market 2018 – Global Trend in Healthcare Industry by Top 10 Players Analysis and Forecasts Till 2023 | Asserts MRFR

Market Research Future published a Premium Research Report on “Global Bile Duct Cancer Market Research Report - Forecast to 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

Pune, India - April 16, 2018 /MarketersMedia/ —

The Global Bile Duct Cancer Market is expected to grow at an approximate CAGR of 9.2% during the forecast period. Bile duct cancer or cholangiocarcinoma is a form of cancer in which epithelial cells are mutated, i.e., they show epithelial differentiation in the bile duct. It is a type of rare neoplasm. According to the National Cancer Institute, in 2014, there were an estimated 66,771 people living with liver and intrahepatic bile duct cancer in the United States. Moreover, the disease is expected to cause 28,920 deaths by the end of 2017 accounting for 4.8% of all cancer deaths. Rates for new liver and intrahepatic bile duct cancer cases have risen by an average 2.7% each year over the last 10 years. Death rates have been estimated to have risen by an average of 2.6% each year over 2005-2014. Such an increase in the prevalence of bile duct cancer has boosted the market. Additionally, rising healthcare expenditures, increasing awareness for the disease and investments in the R&D for treatment procedures is fuelling the market further. However, high cost of treatment and related side effects along with low healthcare expenditures in the developing economies is expected to restrain the market during the forecasted period.

Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/4741 .

Key Players in the Bile Duct Cancer Market:

Pfizer Inc. (U.S.), F. Hoffmann-La Roche Ltd (Europe), Bristol-Myers Squibb Company (U.S.), Teva Pharmaceutical Industries Ltd. (Isreal), Eli Lilly and Company. (U.S.), Sanofi (France), Fresenius Kabi AG (Germany), Mylan N.V. (U.S.), and others.

Bile Duct Cancer Market Regional Analysis:

The Americas dominates the global bile duct cancer market owing to a well-developed healthcare sector. Apart from this, increasing number of patients, increasing healthcare expenditure have boosted the growth of the market in the Americas. According to the Centers for Disease Control and Prevention, U.S. health care spending in 2015, reached $3.2 trillion or $9,990 per person which accounted for 17.8% of the total GDP.

Europe is the second largest bile duct cancer market, which is followed by Asia Pacific. Availability of funds for research, huge patient population and government support for research & development drives the European market.

Asia Pacific is the fastest growing region for the market due to the presence of a huge patient population, continuously developing economies like India and China, and presence of huge opportunity in the market. According to Indian Brand Equity Fund, the per capita healthcare expenditure in India is estimated to grow at a CAGR of 5% during 2008-15 and reach USD 68.6 by 2015.

On the other hand, the Middle East & Africa has the least share in the global bile duct cancer market due to the presence of poor economy especially in Africa region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure.

Global Bile Duct Cancer Market Segmentation:

The Global Bile Duct Cancer Market is segmented on the basis of types, diagnosis, treatment, and end users.

On the basis of types, the market is segmented into intrahepatic, extrahepatic, and others.

On the basis of diagnosis, the market is segmented into blood tests, abdominal imaging, surgery, and others. The diagnosis segment by abdominal imaging is sub segmented into endoscopic retrograde cholangiopancreatography (ERCP), percutaneous transhepatic cholangiography (PTC), magnetic resonance cholangiopancreatography (MRCP), and others.

On the basis of treatment, the market is segmented into chemotherapy, radiotherapy, and others. The chemotherapy segment is sub segmented into 5-fluorouracil, gemcitabine, cisplatin, and others.

On the basis of end users, the market is segmented into hospital &clinics, academic institutes, research organizations and others.

Get Discount @ https://www.marketresearchfuture.com/check-discount/4741 .

Major TOC Bile Duct Cancer Market Research Report – Global Forecast Till 2023:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

TOC Continued….!

LIST OF TABLES

Table 1 Bile Duct Cancer Industry Synopsis, 2017 – 2023

Table 2 Global Bile Duct Cancer Market Estimates And Forecast, 2017 – 2023, (USD Million)

Table 3 Global Bile Duct Cancer Market By Region, 2017 – 2023, (USD Million)

Table 4 Global Bile Duct Cancer Market By Types, 2017 – 2023, (USD Million)

Table 5 Global Bile Duct Cancer Market By Diagnosis, 2017 – 2023, (USD Million)

Table 6 Global Bile Duct Cancer Market By Treatment, 2017 – 2023, (USD Million)

Table 7 Global Bile Duct Cancer Market By End Users, 2017 – 2023, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Bile Duct Cancer Market

Figure 3 Segmentation Market Dynamics For Global Bile Duct Cancer Market

Figure 4 Global Bile Duct Cancer Market Share, By Type 2016

Figure 5 Global Bile Duct Cancer Market Share, By Diagnosis 2016

Figure 6 Global Bile Duct Cancer Market Share, By Treatment 2016

Figure 7 Global Bile Duct Cancer Market Share, By End Users, 2016

Ask to Expertise @ https://www.marketresearchfuture.com/enquiry/4741 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: sales@marketresearchfuture.com
Organization: Market Research Future
Address: Market Research Future, Office No. 528, Amanora Chambers, Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: 6468459312

Source URL: https://marketersmedia.com/bile-duct-cancer-market-2018-global-trend-in-healthcare-industry-by-top-10-players-analysis-and-forecasts-till-2023-asserts-mrfr/331637

For more information, please visit https://www.marketresearchfuture.com/reports/bile-duct-cancer-market-4741

Source: MarketersMedia

Release ID: 331637

More News From The Financial Capital

Volkswagen says it will pay Indian fine even as it appeals

Jan 21, 2019

NEW DELHI — Volkswagen Group said Friday that it will pay a fine of 1 billion rupees ($14.2 million) imposed by India for installing software on vehicles that allegedly cheated pollution testing devices, though it is still appealing the order. The company said it has challenged the National Green Tribunal's order in India's top court. Company spokesman Gagan Mangal declined to say Friday whether the company had transferred the money to India's Central Pollution Control Board. The panel set Friday as the deadline for payment. The company said in a statement that all Volkswagen cars were compliant with emission regulations...

Global stocks rise on hopes for US trade progress

Jan 21, 2019

BEIJING — Global stocks rose Friday after investors saw signs of possible progress toward a resolution of the U.S.-Chinese tariff war. KEEPING SCORE: In Europe, London's FTSE 100 gained 1.4 percent to 6,932 and Germany's DAX advanced 1.5 percent to 11,079. France's CAC 40 rose 1.6 percent to 4,872. On Wall Street, the future for the Dow Jones Industrial Average rose 0.7 percent and that for the Standard & Poor's 500 index was up 0.5 percent. ASIA'S DAY: The Shanghai Composite Index advanced 1.4 percent to 2,596.01 and Hong Kong's Hang Seng gained 1.2 percent to 27,082.01. Tokyo's Nikkei 225...

China, Germany promise closer financial cooperation

Jan 21, 2019

BEIJING — China and Germany promised Friday to open their markets wider to each other's banks and insurers, giving Beijing a burst of positive trade news amid conflicts with Washington and Europe. The two sides also affirmed support for a global trading system that other governments worry is threatened by President Donald Trump's "America first" policies. That followed an annual financial dialogue led by German Finance Minister Olaf Scholz and China's economy czar, Vice Premier Liu He. The initiatives reflect Beijing's determination to make its state-dominated economy more productive and reduce reliance on the U.S. market by building commercial ties...

Chinese stocks rise on hopes for US trade progress

Jan 21, 2019

BEIJING — Chinese stocks rose Friday on signs of possible progress in negotiations over Beijing's tariff war with Washington. KEEPING SCORE: The Shanghai Composite Index advanced 0.8 percent to 2,579.76 and Hong Kong's Hang Seng gained 1 percent to 27,013.20. Tokyo's Nikkei 225 added 1.2 percent to 20,655.08 and Seoul's Kospi advanced 0.5 percent to 2,118.18. Sydney's S&P-ASX 200 was 0.4 percent higher at 5,876.80 while India's Sensex shed 0.1 percent to 36,331.84. Benchmarks in Taiwan, New Zealand and Southeast Asia also rose. US-CHINA TRADE: China announced its economy czar, Vice Premier Liu He, will go to Washington for talks...

China slump squeezes workers, hammers consumer spending

Jan 21, 2019

BEIJING — Yu Mingang had a good job helping Chinese manufacturers prepare to sell shares to the public until the cooling economy derailed those plans. As demand for auditing services sank, the 25-year-old accountant in the eastern city of Hangzhou was laid off in December. Yu tightened his belt: No more movies or eating out. He put off buying a computer. "I pay rent out of my savings," Yu said. The downturn is squeezing urban workers and entrepreneurs the ruling Communist Party is counting on to help transform China from a low-wage factory into a prosperous consumer market. Headline economic...

Sign up now!

The Financial Capital is your independent source for finance information and advice. We provide insights and offer advice from financial experts so you can make the best decisions.

Contact us: sales[at]thefinancialcapital.com